News & Events
Breakthrough Liver Cancer Treatment gets Green Light
26 February, 2010
Denmead, England. Acculis Limited today announced the regulatory clearance of its revolutionary new device for destroying unwanted tissues, such as liver tumours. The clearance under the European CE Mark system allows the company to begin deliveries for treating patients throughout Europe and elsewhere where the CE Mark system is recognised.
Acculis Sponsors EHPBA
24 April, 2009
We have great pleasure in inviting you to attend the 8th Congress of the European Hepato-Pancreato-Biliary Association at Megaron, the Athens International Conference Centre on 18-20 June 2009.
Acculis Exhibits at ASGBI
24 April, 2009
The 2009 International Surgical Congress of the Association of Surgeons of Great Britain and Ireland is a three day meeting taking place at the Scottish Exhibition and Conference Centre (SECC) in Glasgow from Wednesday 13th to Friday 15th May 2009.
Acculis exhibits at ANZHPBA
07 October, 2008
This association has been established to assist in the advancement of management of diseases of the liver, biliary tract, and pancreas. The success of the organisation is dependent on active, involved and interested membership.
Microsulis exhibit at AAGL in Las Vegas
07 October, 2008
The AAGL Global Congress is the pre-eminent meeting for physicians interested in providing optimal patient care through minimally invasive gynecology. Designed to meet the needs of practicing surgeons, residents and fellows, operating room personnel and other allied healthcare professionals, the Congress covers traditional topics as well as presentations of “cutting edge” material. With opportunities to discuss and share discoveries, you will experience excellence in formal, informal and collegial education.
Acculis exhibit at the American College of Surgeons Clinical Congress
07 October, 2008
The American College of Surgeons will present its 94th Clinical Congress, October 12-16, 2008 at the Moscone Convention Center, San Francisco, CA. Programs at the Clinical Congress are developed to advance surgeons’ ongoing efforts to achieve the best clinical outcomes for their patients.
International Launch of Acculis Microwave Tissue Ablation System for the Coagulation of Soft Tissue
22 September, 2008
Acculis Limited, the leading UK microwave ablation system company, today announced the international release of their pioneering Microwave Tissue Ablation system for the coagulation of soft tissue in open surgery. The FDA 510(k) cleared device is the first microwave ablation system to offer large fast spherical ablations from single needle placements, superseding the performance of lower power RF or other current microwave ablation systems.
Top US Cancer Hospitals Install MTA
27 June, 2008
MD Anderson and Memorial Sloan Kettering have become the lates top cancer hospitals to install the new Acculis MTA microwave ablation system
Multi million dollar funding package for Acculis Limited microwave cancer treatment
01 June, 2008
Acculis Limited has finalised a multi million dollar funding package to complete commercial development of the needle probe version of its recently launched MTA high power microwave coagulation system. The funding has been secured from private equity sources in the USA.
First USA use of MTA at Saint Raphael
22 May, 2008
Scott Helton, M.D., chief of surgery at the Hospital of Saint Raphael, New Haven, Connecticut, an internationally recognized liver surgeon, became the first in the USA to use the new Acculis microwave cancer-fighting technology to destroy liver tumours.
